Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Am J Transplant. 2011 Dec 7;12(2):438–446. doi: 10.1111/j.1600-6143.2011.03857.x

Figure 3. Increased CXCL10 in the setting of acute rejection.

Figure 3

Panel A shows paired analysis of patients who had a period of nonrejection followed by the first episode of rejection. The “before rejection” represents the mean of all BALF CXCL10 before the first episode of rejection. A total of 22 patients met this criterion with median before rejection CXCL10 levels of 13.9 versus median first rejection levels of 43.4 (p < 0.01). Panel B shows the comparison of mean CXCL10 levels leading up to and including the first rejection in the 22 patients with at least one episode of rejection to mean CXCL10 levels in the 11 nonrejectors (41.3 vs. 29.9 pg/mL, p = 0.67).